Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation?
(2008) In European Heart Journal 29(7). p.915-922- Abstract
- Aims To assess the relation between the atrial fibrillation (AF) subtype and thrombo-embolic events. Methods and results The observational Euro Heart Survey on AF (2003-04) enrolled 1509 paroxysmal, 1109 persistent, and 1515 permanent AF patients, according to the 2001 American College of Cardiology, American Heart Association, and the European Society of Cardiology guidelines definitions. A 1 year follow-up was performed. Permanent AF patients had at baseline a worse stroke risk profile than paroxysmal and persistent AF patients. In paroxysmal AF, the risk for stroke, any thrombo-embolism, major bleeding and the combined endpoint of cardiovascular mortality, any thrombo-embolism, and major bleeding was comparable with persistent and... (More)
- Aims To assess the relation between the atrial fibrillation (AF) subtype and thrombo-embolic events. Methods and results The observational Euro Heart Survey on AF (2003-04) enrolled 1509 paroxysmal, 1109 persistent, and 1515 permanent AF patients, according to the 2001 American College of Cardiology, American Heart Association, and the European Society of Cardiology guidelines definitions. A 1 year follow-up was performed. Permanent AF patients had at baseline a worse stroke risk profile than paroxysmal and persistent AF patients. In paroxysmal AF, the risk for stroke, any thrombo-embolism, major bleeding and the combined endpoint of cardiovascular mortality, any thrombo-embolism, and major bleeding was comparable with persistent and permanent AF, in both univariable and multivariable analyses. Compared with AF patients without stroke, patients suffering from a stroke had a comparable frequency and duration of AF attacks, but tended to have a worse stroke risk profile at baseline. During 1 year following cardioversion, paroxysmal AF patients had a higher risk for stroke (P = 0.029) and any thrombo-embolism (P = 0.001) than persistent AF patients. Conclusion In the Euro Heart Survey, paroxysmal AF had a comparable risk for thrombo-embolic events as persistent and permanent AF. This observation strengthens the guideline recommendation not to consider the clinical AF subtype when deciding on anticoagulation. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1208450
- author
- Nieuwlaat, Robby ; Dinh, Trang ; Olsson, Bertil LU ; Camm, A. John ; Capucci, Alessandro ; Tieleman, Robert G. ; Lip, Gregory Y. H. and Crijns, Harry J. G. M.
- organization
- publishing date
- 2008
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- paroxysmal atrial fibrillation, stroke, anticoagulation, thrombo-embolism, atrial fibrillation, subtype
- in
- European Heart Journal
- volume
- 29
- issue
- 7
- pages
- 915 - 922
- publisher
- Oxford University Press
- external identifiers
-
- wos:000254684900017
- scopus:41849119802
- pmid:18334476
- ISSN
- 1522-9645
- DOI
- 10.1093/eurheartj/ehn101
- language
- English
- LU publication?
- yes
- id
- 97793058-b16a-4379-8bec-93040af16750 (old id 1208450)
- date added to LUP
- 2016-04-01 14:42:53
- date last changed
- 2022-04-22 04:51:44
@article{97793058-b16a-4379-8bec-93040af16750,
abstract = {{Aims To assess the relation between the atrial fibrillation (AF) subtype and thrombo-embolic events. Methods and results The observational Euro Heart Survey on AF (2003-04) enrolled 1509 paroxysmal, 1109 persistent, and 1515 permanent AF patients, according to the 2001 American College of Cardiology, American Heart Association, and the European Society of Cardiology guidelines definitions. A 1 year follow-up was performed. Permanent AF patients had at baseline a worse stroke risk profile than paroxysmal and persistent AF patients. In paroxysmal AF, the risk for stroke, any thrombo-embolism, major bleeding and the combined endpoint of cardiovascular mortality, any thrombo-embolism, and major bleeding was comparable with persistent and permanent AF, in both univariable and multivariable analyses. Compared with AF patients without stroke, patients suffering from a stroke had a comparable frequency and duration of AF attacks, but tended to have a worse stroke risk profile at baseline. During 1 year following cardioversion, paroxysmal AF patients had a higher risk for stroke (P = 0.029) and any thrombo-embolism (P = 0.001) than persistent AF patients. Conclusion In the Euro Heart Survey, paroxysmal AF had a comparable risk for thrombo-embolic events as persistent and permanent AF. This observation strengthens the guideline recommendation not to consider the clinical AF subtype when deciding on anticoagulation.}},
author = {{Nieuwlaat, Robby and Dinh, Trang and Olsson, Bertil and Camm, A. John and Capucci, Alessandro and Tieleman, Robert G. and Lip, Gregory Y. H. and Crijns, Harry J. G. M.}},
issn = {{1522-9645}},
keywords = {{paroxysmal atrial fibrillation; stroke; anticoagulation; thrombo-embolism; atrial fibrillation; subtype}},
language = {{eng}},
number = {{7}},
pages = {{915--922}},
publisher = {{Oxford University Press}},
series = {{European Heart Journal}},
title = {{Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation?}},
url = {{http://dx.doi.org/10.1093/eurheartj/ehn101}},
doi = {{10.1093/eurheartj/ehn101}},
volume = {{29}},
year = {{2008}},
}